Maple Rock Capital Partners Inc. Bausch Health Companies Inc. Transaction History
Maple Rock Capital Partners Inc.
- $2.6 Billion
- Q1 2025
A detailed history of Maple Rock Capital Partners Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 6,797,500 shares of BHC stock, worth $44 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
6,797,500
Previous 5,300,000
28.25%
Holding current value
$44 Million
Previous $42.7 Million
2.95%
% of portfolio
1.69%
Previous 1.34%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
269Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$225 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$196 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$171 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$152 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$84.2 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.34B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...